Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CDW Corporation | CDW | Nov 25, 2024 | 171.75 | +0.59 |
CECO Environmental Corp. | WCE | Nov 25, 2024 | 29.82 | +4.27 |
Ceconomy AG American Depositary Receipts - Unsponsored | MEOD | Nov 25, 2024 | 0.56 | +1.83 |
Ceconomy AG. | CEC | Nov 25, 2024 | 3.10 | +4.87 |
Cedergrenska | 41C | Nov 25, 2024 | 2.22 | -2.63 |
Cegedim | C7E | Nov 25, 2024 | 10.65 | -0.93 |
Cel-Sci Corp. | LSRM | Nov 25, 2024 | 0.59 | +4.17 |
Celanese Corp | DG3 | Nov 25, 2024 | 71.38 | -1.08 |
Celestica, Inc. | CTW0 | Nov 25, 2024 | 82.00 | -4.09 |
CELL IMPACT AB | ICLA | Nov 25, 2024 | 0.01 | -29.80 |
CellaVision | C26 | Nov 25, 2024 | 19.56 | +7.00 |
Cellcom Israel Limited | F5U | Nov 25, 2024 | 4.74 | +0.42 |
Celldex Therapeutics, Inc. | TCE2 | Nov 25, 2024 | 25.80 | +4.03 |
Cellectar Biosciences | NV4 | Nov 25, 2024 | 1.47 | 0.00 |
Cellectis | ZVA | Nov 25, 2024 | 1.73 | +0.35 |
Cellectis S.A. - American Depositary Shares | ZVAA | Nov 25, 2024 | 1.73 | +0.58 |
CELLINK B | 49Z | Nov 25, 2024 | 3.60 | +17.11 |
Cellnex Telecom S.A. | 472 | Nov 25, 2024 | 32.64 | +0.71 |
Cellnex Telecom SA Unsponsored ADR (Spain) | 4720 | Nov 25, 2024 | 15.70 | +2.61 |
Cellular Goods Plc | 6XS | Nov 25, 2024 | 0.00 | 0.00 |
Celon Pharma SA | 8RP | Nov 25, 2024 | 5.84 | +2.46 |
Celsion Corporation | CBO | Nov 25, 2024 | 0.76 | +15.15 |
Celsius Resources Limited | FX8 | Nov 25, 2024 | 0.01 | 0.00 |
Celtic plc | CCP | Nov 25, 2024 | 1.88 | 0.00 |
Celyad Oncology | 1C0 | Nov 25, 2024 | 0.61 | +0.16 |
Cemat | 1X9 | Nov 25, 2024 | 0.13 | -1.18 |
CEMBRE S.P.A. EO 0,52 | J0L | Nov 25, 2024 | 41.40 | -0.12 |
Cementir Holding N.V. | 3PC | Nov 25, 2024 | 11.04 | -2.30 |
Cementos Pacasmayo S.A.A. American Depositary Shares (Each r | EPCC | Nov 25, 2024 | 5.50 | -1.79 |
Cemex S.A.B. De C.V. | CEXA | Nov 25, 2024 | 5.30 | +2.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.